Estonia–Latvia programme 2021–2027 implemented under the European territorial cooperation goal (Interreg)
2 – Jointly and smartly growing businesses
Programme specific objective
2.1 – Enhancing sustainable growth and competitiveness of SMEs and job creation in SMEs, including by productive investments
TBD Pharmatech Ltd.
Latvian Institute of Organic Synthesis (LIOS)
Project leader at LIOS
Dr. Gints Smits
€ 582 436.25
€ 465 949.00
€ 115 580.00
The primary goal of the project PharmaBoost is to pioneer an economically and environmentally sustainable production technology of an active pharmaceutical ingredient crucial for a vital smoking cessation medication. Implementation of the project will contribute to advancing pharmaceutical development and promoting pharmaceutical innovations within the Baltic States.
The TBD Pharmatech and LIOS partnership aims to establish a more resilient pharmaceutical landscape reinforced by a proficient workforce, cutting-edge infrastructure, and cross-border cooperation.